Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum
S Sharma, Mohnish Grover, Shruti Bhargava, et al.
The Journal of Laryngology & Otology (2021) Vol. 135, Iss. 5, pp. 442-447
Open Access | Times Cited: 386

Showing 1-25 of 386 citing articles:

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Awadhesh Kumar Singh, Ritu Singh, Shashank Joshi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102146-102146
Open Access | Times Cited: 992
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, et al.
Mycoses (2021) Vol. 64, Iss. 12, pp. 1452-1459
Open Access | Times Cited: 244
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 201
Mucormycosis: An opportunistic pathogen during COVID-19
Mahalaxmi Iyer, Kaavya Jayaramayya, Dhivya Venkatesan, et al.
Environmental Research (2021) Vol. 201, pp. 111643-111643
Open Access | Times Cited: 179
Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Lav Selarka, Suktara Sharma, Dinesh Kumar Saini, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1253-1260
Open Access | Times Cited: 164
COVID-19 and mucormycosis superinfection: the perfect storm
Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 833-853
Open Access | Times Cited: 156
COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India
Jesil Mathew Aranjani, Atulya Manuel, Habeeb Ibrahim Abdul Razack, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 11, pp. e0009921-e0009921
Open Access | Times Cited: 106
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 68
COVID-19-associated mucormycosis: Case report and systematic review
Ahmet Dilek, Reşat Özaras, Şevket Özkaya, et al.
Travel Medicine and Infectious Disease (2021) Vol. 44, pp. 102148-102148
Open Access | Times Cited: 85
Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections
Ke Peng, Lalitkumar K. Vora, Ismaiel A. Tekko, et al.
Journal of Controlled Release (2021) Vol. 339, pp. 361-380
Open Access | Times Cited: 84
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 921-921
Open Access | Times Cited: 82
Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study
Tarjani Vivek Dave, Akshay Gopinathan Nair, Raghuraj Hegde, et al.
Ophthalmic Plastic and Reconstructive Surgery (2021) Vol. 37, Iss. 5, pp. 488-495
Open Access | Times Cited: 81
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
Maryam Roudbary, Sunil Kumar, Awanish Kumar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 720-720
Open Access | Times Cited: 81
Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review
Anson Jose, Shagun Singh, Ajoy Roychoudhury, et al.
Journal of Maxillofacial and Oral Surgery (2021) Vol. 20, Iss. 3, pp. 373-380
Open Access | Times Cited: 77
Fungal infections diagnosis – Past, present and future
Alexandre Mendonça, Helena Santos, Ricardo Franco‐Duarte, et al.
Research in Microbiology (2021) Vol. 173, Iss. 3, pp. 103915-103915
Open Access | Times Cited: 68
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
Hassan Abolhassani, Nils Landegren, Paul Bastard, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 471-483
Open Access | Times Cited: 60
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 4, pp. 466-479
Open Access | Times Cited: 40
COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review
Asma Al Balushi, Ahmed Al Ajmi, Qais Al Sinani, et al.
International Journal of Infectious Diseases (2022) Vol. 121, pp. 203-210
Open Access | Times Cited: 37
Surge of mucormycosis during the COVID-19 pandemic
Paulami Dam, Marlon H. Cardoso, Sukhendu Mandal, et al.
Travel Medicine and Infectious Disease (2023) Vol. 52, pp. 102557-102557
Open Access | Times Cited: 29
Infectious eye disease in the 21st century—an overview
Gerry Clare, John H. Kempen, Carlos Pavésio
Eye (2024) Vol. 38, Iss. 11, pp. 2014-2027
Open Access | Times Cited: 10
Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital
Abha Kumari, Nusumu Purnachandra Rao, Uma Patnaik, et al.
Medical Journal Armed Forces India (2021) Vol. 77, pp. S289-S295
Open Access | Times Cited: 53
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
Alfonso J. Rodríguez‐Morales, Ranjit Sah, José Oñate, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 50
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management
Farah Yasmin, Hala Najeeb, Aisha Naeem, et al.
Diseases (2021) Vol. 9, Iss. 4, pp. 65-65
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top